EquityZen Growth Technology Fund LLC - Series 1997
Raised
$188K
Investors
11
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1997 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors, raising $188K from 11 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. This is part of EquityZen's platform of 1,889 pre-IPO secondary market SPVs, with filing dated March 12, 2025.
This pre-IPO vehicle follows the standard EquityZen template: a sub-$1M single-company SPV using dual 506(b)/3(c)(1) exemptions with a $10K retail-accessible minimum. The modest raise and investor count are typical for EquityZen's series structure, which aggregates small checks to access pre-IPO shares in growth-stage technology companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.